MediPharm Labs Corp. (TSE:LABS – Get Free Report) reached a new 52-week low during mid-day trading on Monday. The stock traded as low as C$0.06 and last traded at C$0.06, with a volume of 290,446 shares traded. The stock had previously closed at C$0.06.
MediPharm Labs Price Performance
The company’s 50-day moving average is C$0.07 and its 200-day moving average is C$0.07. The firm has a market cap of C$27.77 million, a price-to-earnings ratio of -6.50 and a beta of -0.60. The company has a current ratio of 2.69, a quick ratio of 3.10 and a debt-to-equity ratio of 1.19.
About MediPharm Labs
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.
Further Reading
- Five stocks we like better than MediPharm Labs
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
